Join us for an "Innovation After Hours" event in Boulder on October 10, 2024, as we explore the cutting-edge role of AI in drug discovery. Our expert panel features Joel Dudley, Partner at Innovation Endeavors, Doug Chapnick, Founder & CEO of Bioloomics, and Hannah Gordon, Chief Product Officer at Enveda. Don't miss this opportunity to learn how AI is revolutionizing the future of medicine! |
